Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Chronic Pancreatitis

In brief

Tanezumab is effective in reducing the pain associated with chronic pancreatitis.

Key facts

Study ID
NCT01146561
Run by
Pfizer
People needed
2
Starts
2010-10-13
Expected to finish
2011-03-22
Last updated by the study team
2021-03-23

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.